The DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index; none of the 79 sources its claims cite is checked for support yet.
Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span
Open accessAbstract
BACKGROUND: Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive disorder with loss of function mutations of lipoprotein lipase resulting in hypertriglyceridemia and accumulation of chylomicrons in plasma, often leading to acute pancreatitis. The mainstay of treatment is a specialized very-low-fat diet. Even adhering to the diet, some patients may experience high triglycerides and pancreatitis. There currently are no comprehensive dietary guidelines. OBJECTIVE: To report best practices and develop comprehensive dietary guidelines for nutrition therapy in patients with FCS. METHODS: Registered dietitian nutritionists (RDNs) convened to develop this report based on experience treating patients with FCS and a review of current literature on the topic. One author provided a patient perspective of living with FCS. RESULTS: This report provides guidelines and rationales for nutrition therapy associated with FCS across the life span. The top global guidelines are to (1) limit fat to <15 to 20 g per day (<10%-15% of total daily energy intake); (2) meet recommendations for essential fatty acids: α-linolenic acid and linoleic acid; (3) choose complex carbohydrate foods while limiting simple and refined carbohydrate foods; (4) supplement with fat-soluble vitamins, minerals, and medium-chain triglyceride oil, as needed; (5) adjust calories for weight management. Recommended foods include vegetables, whole grains, legumes, lean protein foods, fruits in limited amounts, and fat-free milk products without added sugars. Foods to avoid include alcohol and products high in sugar. CONCLUSIONS: These patient-centered nutrition guidelines provide guidance to help patients adhere to the recommended diet and optimize nutritional needs.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This expert-panel article provides patient-centered, lifespan dietary guidelines for familial chylomicronemia syndrome (FCS), centered on a very-low-fat diet and multidisciplinary care. It synthesizes literature and clinical experience because no randomized trials exist for this rare disorder.
Key findings
- The panel recommends a very-low-fat diet of less than 15–20 g fat per day or less than 10%–15% of total daily calories, with fat distributed throughout the day; the target is to maintain triglycerides below 1000 mg/dL, and below 500 mg/dL during pregnancy.
- Patients should meet essential fatty acid needs at 2%–4% of daily calories, may use medium-chain triglyceride oil to add calories, limit total carbohydrate to no more than 60% of daily calories, avoid added sugars and alcohol, and monitor/supplement fat-soluble vitamins A, D, E, and K as needed.
- FCS affects 1 to 2 per million people; triglyceride levels may range from 1500 to 15,000 mg/dL or higher, acute pancreatitis was reported by 42% of patients with FCS, and acute pancreatitis risk increases by 4% for every 100 mg/dL rise in triglycerides.
- Patients report visiting at least 5 physicians (range 1–30) before diagnosis; psychosocial burden includes 22% reporting depressive episodes and only 22% able to sustain full-time employment in an interim analysis.
Methods
- Design: expert-panel best-practice guidelines developed by registered dietitian nutritionists (RDNs) with experience treating FCS, incorporating the perspective of one patient with FCS.
- Data/sample: review of current clinical and scientific literature plus personal clinical experience; no randomized controlled trials or meta-analyses were available because of the rarity of FCS.
- Analysis: consensus recommendations organized across the life span and special populations, including pediatrics, pregnancy, diabetes, acute pancreatitis, and chronic pancreatitis.
Limitations
- Stated: the guidelines are based on a literature review and expert opinion of RDNs; owing to low FCS prevalence, there are no randomized controlled clinical trials or robust data sets, so recommendations rest on limited observations and clinical experience.
- Evident from the text: no formal systematic review or prospective validation is described; the patient perspective comes from a single patient; some recommendations are generalized from hypertriglyceridemia rather than FCS-specific (e.g., physical activity); and the work was funded by Akcea Therapeutics, including writing support.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 79 cited sources checked · 0 supported · 0 flagged
None of the sources cited for this claim have been checked yet.
In the paper
“Effectiveness of omega-3 fatty acids, routinely used in pharmacologic doses for treatment of severe HTG, has been inconsistent in patients with FCS.3,[16][17][18]20”
What the sources say
- Not checked yetcites [3] Brahm, 2015, Chylomicronaemia–current diagnosis and future therapies, Nat Rev Endocrinol source
- Not checked yetcites [16] Helk, 2016, Effects of two therapeutic dietary regimens on primary chylomicronemia in paediatric age: a retrospective data analysis, Eur J Clin Nutr source
- Not checked yetcites [17] Yuan, 2007, Hypertriglyceridemia: its etiology, effects and treatment, CMAJ source
- Not checked yetcites [18] Connor, 1993, N-3 fatty acids from fish oil. Effects on plasma lipoproteins and hypertriglyceridemic patients, Ann NY Acad Sci source
- Not checked yetcites [19] Pschierer, 1995, Primary chylomicronemia in patients with severe familial hypertriglyceridemia responds to long-term treatment with (n-3) fatty acids, J Nutr source
- Not checked yetcites [20] Brunzell, 2007, Hypertriglyceridemia, N Engl J Med source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Even when patients adhere to the very-low-fat diet and are monitored by a registered dietitian nutritionist (RDN), TG levels may remain dangerously high.3,20,21”
What the sources say
- Not checked yetcites [3] Brahm, 2015, Chylomicronaemia–current diagnosis and future therapies, Nat Rev Endocrinol source
- Not checked yetcites [20] Brunzell, 2007, Hypertriglyceridemia, N Engl J Med source
- Not checked yetcites [21] Bryant, 2013, Lessons learned from the clinical development and market authorization of Glybera, Hum Gene Ther Clin Dev source
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“A delay in diagnosis may place patients at an increased risk for acute pancreatitis.11”
What the sources say
- Not checked yetcites [11] Berglund, 2012, Endocrine society. Evaluation and treatment of hypertriglyceridemia: An Endocrine Society clinical practice guideline, J Clin Endocrinol Metab source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“A lack of familiarity with FCS among health care providers may be one reason patients with FCS report visiting at least 5 physicians (range 1-30) before receiving a diagnosis of FCS. 13”
What the sources say
- Not checked yetcites [13] Davidson, 2017, The burden of familial chylomicronemia syndrome: interim results from the IN-FOCUS study, Expert Rev Cardiovasc Ther source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“People with FCS cannot metabolize chylomicron-associated TGs. 5”
What the sources say
- Not checked yetcites [5] Hegele, 2014, The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis and management, Lancet Diabetes Endocrinol source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No comprehensive best practice dietary guidelines across the life span exist.”
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Currently, the only published guidelines for managing diet restrictions in patients with FCS are for infants, children, and adolescents.22”
What the sources say
- Not checked yetcites [22] Williams, 2016, Editorial commentary: Dietary management of familial chylomicronemia syndrome, J Clin Lipidol source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“This is caused by increased liver synthesis of TGs in response to elevated estrogen levels.47”
What the sources say
- Not checked yetcites [47] Bolla, 2012, Chylomicronemia syndrome in pregnancy: a case report of an acute necrotizing pancreatitis, Geburtshilfe Frauenheilkd source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“However, the Food and Agriculture Organization of the United Nations and the World Health Organization set the minimum intake of LA and ALA to prevent deficiency symptoms in adults as 2.5% and 0.5% of daily energy intake, respectively.26”
What the sources say
- Not checked yetcites [26] Elmadfa, 2009, Fats and fatty acid requirements for adults, Ann Nutr Metab source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“During attacks of acute pancreatitis, early aggressive IV hydration with 250 to 500 mL/h may prevent intravascular volume depletion and pancreatic necrosis.50,51”
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 19
- Probably not a substantial claim. 17
None of the sources cited for this claim have been checked yet.
In the paper
“Other symptoms of FCS are recurrent pancreatitis, severe abdominal pain ranging from mild to incapacitating (with or without pancreatitis), hepatosplenomegaly, lipemic plasma, eruptive xanthomas, lipemia retinalis, 1,14,15 and decreased quality of life.13”
What the sources say
- Not checked yetcites [1] Burnett, 1999, Familial lipoprotein lipase deficiency
- Not checked yetcites [14] Brunzell, 2001, Familial lipoprotein lipase deficiency, apo C-II deficiency and hepatic lipase deficiency
- Not checked yetcites [15] Ahmad, 2017, Building a better understanding of the burden of disease in familial chylomicronemia syndrome, Expert Rev Clin Pharmacol source
- Not checked yetcites [13] Davidson, 2017, The burden of familial chylomicronemia syndrome: interim results from the IN-FOCUS study, Expert Rev Cardiovasc Ther source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Acute pancreatitis can lead to chronic pancreatitis, 10,11 signs of exocrine or endocrine pancreatic insufficiency, including pancreatic (type 3c) diabetes, 12 and can be fatal.”
What the sources say
- Not checked yetcites [10] Yang, 2009, The role of free fatty acids, pancreatic lipase and Ca2+ signalling in injury of isolated acinar cells and pancreatitis model in lipoprotein lipase-deficient mice, Acta Physiol (Oxf) source
- Not checked yetcites [11] Berglund, 2012, Endocrine society. Evaluation and treatment of hypertriglyceridemia: An Endocrine Society clinical practice guideline, J Clin Endocrinol Metab source
- Not checked yetcites [12] Gaudet, 2013, Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: An open-label trial, Gene Ther source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“The very-low-fat diet is recommended to reduce TG levels below 1000 mg/dL.18”
What the sources say
- Not checked yetcites [18] Connor, 1993, N-3 fatty acids from fish oil. Effects on plasma lipoproteins and hypertriglyceridemic patients, Ann NY Acad Sci source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“Accumulating TGs may impair pancreatic blood flow and activate inflammatory processes, resulting in acute pancreatitis. [6][7]7][8]”
What the sources say
- Not checked yetcites [6][7]7][8]
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In addition to a restricted diet, patients with FCS need to avoid drugs known to increase TG levels, including diuretics, systemic steroids, oral estrogens, antihypertensive drugs, retinoids, isotretinoin, bile acid sequestrants, protease inhibitors, immunosuppressants, antidepressants (sertraline), and beta-adrenergic blocking agents. 1”
What the sources say
- Not checked yetcites [1] Burnett, 1999, Familial lipoprotein lipase deficiency
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“It is estimated that severe HTG is the cause of 10% of all cases of acute pancreatitis.7”
What the sources say
- Not checked yetcites [7] Valdivielso, 2014, Current knowledge of hypertriglyceridemic pancreatitis, Eur J Intern Med source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“acute pancreatitis may have a more severe course, leading to longer median hospital stays, increased need for intensive care, a higher rate of pancreatic necrosis, more frequent persistent organ failure, and higher rates of mortality.9”
What the sources say
- Not checked yetcites [9] Nawaz, 2015, Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis, Am J Gastroenterol source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Acute pancreatitis was reported by 42% of patients with FCS, making it the most common and potentially severe comorbidity.13”
What the sources say
- Not checked yetcites [13] Davidson, 2017, The burden of familial chylomicronemia syndrome: interim results from the IN-FOCUS study, Expert Rev Cardiovasc Ther source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“When LPL is functioning, it helps metabolize TGs into free fatty acids through the LPL-dependent pathway.5”
What the sources say
- Not checked yetcites [5] Hegele, 2014, The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis and management, Lancet Diabetes Endocrinol source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
None of the sources cited for this claim have been checked yet.
In the paper
“Triglyceride (TG) levels in individuals with FCS are often 10-fold to 100-fold or more above normal (,150 mg/dL) and may range from 1500 to 15,000 mg/ dL or higher.4,5”
What the sources say
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Familial chylomicronemia syndrome (FCS) is a rare, autosomal recessive genetic disorder that affects 1 to 2 per million people.1,2”
What the sources say
- Not checked yetcites [1] Burnett, 1999, Familial lipoprotein lipase deficiency
- Not checked yetcites [2] Pouwels, 2008, Severe hypertriglyceridaemia as a result of familial chylomicronaemia: the Cape Town experience, S Afr Med J
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Overall carbohydrate intake should be limited based on an individual's needs, and to balance macronutrient intake in diet to ,60% daily caloric intake as excess carbohydrates and simple sugar are metabolized into fat, contributing to increased TG levels.33”
What the sources say
- Not checked yetcites [33] National Cholesterol Education Program (NCEP) Expert Panel on Detection, 2002, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), Circulation source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
In the paper
“Despite the critical need for a very-low-fat intake, dietary fat retains a pivotal role in provision of adequate calories, preventing EFA deficiency, absorption of fat-soluble vitamins, brain development in infants and children, and increasing satiety.24”
What the sources say
- Not checked yetcites [24] Mahan, 2012
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Adequate provision of EFA is necessary to prevent EFA deficiency, characterized by a triene: tetraene ratio of greater than 0.4 or phenotypic signs, including inadequate growth in pediatric patients, dry or dull hair, dry or scaly skin, skin lesions, soft and brittle nails, and impaired wound healing.25”
What the sources say
- Not checked yetcites [25] McCray, 2011, Nutritional management of chyle leaks: an update, Pract Gastroenterol
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Owing to the low prevalence of FCS, there are no randomized controlled clinical trials or robust data sets.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Chylomicron concentrations increase as TG levels rise, and both are known causes of acute pancreatitis.7”
What the sources say
- Not checked yetcites [7] Valdivielso, 2014, Current knowledge of hypertriglyceridemic pancreatitis, Eur J Intern Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Avoidance of alcohol by patients with FCS is important, as it may cause acute exaggerated TG elevations and exacerbations of acute pancreatitis episodes.7,36”
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Pediatric requirements for fluid are calculated using a child's body surface area.40”
What the sources say
- Not checked yetcites [40] Mosteller, 1987, Simplified calculation of body surface area, N Engl J Med source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“These may be due to feelings of isolation or due to tiring of following the strict verylow-fat diet.42,43”
What the sources say
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“MCT oil is used to increase overall caloric intake and adjust the macronutrient distribution of the diet, helping to prevent excessive percentage of overall caloric intake from carbohydrate sources.28,29”
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“The high TG levels allow the mother to spare glucose for the fetus and allow placental steroidogenesis.47”
What the sources say
- Not checked yetcites [47] Bolla, 2012, Chylomicronemia syndrome in pregnancy: a case report of an acute necrotizing pancreatitis, Geburtshilfe Frauenheilkd source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, these guidelines are based on limited observations and clinical experience.”
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“EPI occurs when 90% of the pancreatic enzyme output is diminished, 54 and pancreatic enzyme replacement therapies may be necessary in such cases.”
What the sources say
- Not checked yetcites [54] Ferrone, 2007, Pancreatic enzyme pharmacotherapy, Pharmacotherapy source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“To prevent EFA deficiency, a minimum intake of 2% to 4% daily caloric intake from LA and ALA is recommended.26”
What the sources say
- Not checked yetcites [26] Elmadfa, 2009, Fats and fatty acid requirements for adults, Ann Nutr Metab source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“Metabolic syndrome and insulin resistance may lead to further elevated TG levels, and should be prevented.35”
What the sources say
- Not checked yetcites [35] Miller, 2011, Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association, Circulation source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“These best practice guidelines (summarized in Table 5) are based on a review of the literature and expert opinion of RDNs with experience providing medical nutrition therapy for patients with FCS.”
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Many families, caregivers, and patients benefit from communicating and connecting with other people with FCS, which can occur through the FCS Foundation (www. livingwithfcs.org;www.facebook.com/livingwithfcs).”
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✗ Checkable: fails✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. It may be too vague to check against evidence. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The support of the health care team or the FCS Foundation may enable patients with FCS to better adhere to and manage the very-low-fat diet.”
Tests✓ Asserted: passes✗ Checkable: fails✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. It may be too vague to check against evidence. The paper may give no reason why it holds.
- Rests on an assumption: The very-low-fat diet is essential for FCS.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It is possible that people with FCS who feel empowered to control and individualize their diet to their own tastes and needs may increase their adherence to the very-low-fat diet.”
Tests✓ Asserted: passes✗ Checkable: fails✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. It may be too vague to check against evidence. The paper may give no reason why it holds.
- Rests on an assumption: The very-low-fat diet is essential for FCS.
In the paper
“It is important to consider and discuss the psychosocial implications of dietary management with FCS patients, including risk for feelings of isolation, tension, anxiety, and development of eating disorders.[41][42][43]”
What the sources say
- Not checked yetcites [41][42][43]
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Twenty-two percent of FCS patients reported depressive episodes, and other cognitive symptoms such as impaired memory, difficulty concentrating, fatigue, and weakness.”
What the sources say
- Not checked yetcites [13] Davidson, 2017, The burden of familial chylomicronemia syndrome: interim results from the IN-FOCUS study, Expert Rev Cardiovasc Ther source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Patients with FCS benefit from working with a multidisciplinary team.”
Tests✓ Asserted: passes✗ Checkable: fails✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. It may be too vague to check against evidence. The paper may give no reason why it holds.
In the paper
“This approach empowers patients with FCS to discover and use their own innate ability to gain mastery over their disease.62”
What the sources say
- Not checked yetcites [62] Anderson, 2010, Patient empowerment: myths and misconceptions, Patient Educ Couns source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
The paper relies on this without support.
FCS is characterized by severe fasting hypertriglyceridemia due to a deficiency in either the enzyme lipoprotein lipase (LPL) or other proteins necessary for proper LPL function.
“FCS is characterized by severe fasting hypertriglyceridemia (HTG) due to a deficiency in either the enzyme lipoprotein lipase (LPL) or other proteins necessary for proper LPL function.”
The paper relies on this without support.
In FCS, HTG results from the inability to metabolize TGs and other fats.
“In FCS, HTG results from the inability to metabolize TGs and other fats.”
The paper relies on this without support.
Fats are absorbed through the small intestine, where chylomicrons are formed.
“Fats are absorbed through the small intestine, where chylomicrons are formed.”
The paper relies on this without support.
Although TGs are also metabolized via the LPL-independent pathway, this pathway cannot compensate for the loss of LPL function.
“Although TGs are also metabolized via the LPL-independent pathway, this pathway cannot compensate for the loss of LPL function.”
The paper relies on this without support.
In FCS, chylomicrons, chylomicron remnants, and TG-rich lipoproteins cannot be metabolized and accumulate in the plasma.
“In FCS, chylomicrons, chylomicron remnants, and TGrich lipoproteins cannot be metabolized and accumulate in the plasma.”
The paper relies on this without support.
Acute pancreatitis is one of the severe, debilitating symptoms of FCS.
“Acute pancreatitis is one of the severe, debilitating symptoms of FCS.”
The paper relies on this without support.
Current medical nutrition therapy for FCS is a very-low-fat diet consisting of total fat intake <10% to 15% daily calories (ie, <15-20 g of fat per day) with limited simple, refined carbohydrates and avoidance of alcohol.
“Because patients with FCS cannot metabolize TGs and fats, current medical nutrition therapy is a very-low-fat diet consisting of total fat intake ,10% to 15% daily calories (ie, ,15-20 g of fat per day) with limited simple, refined carbohydrates and avoidance of alcohol.”
The paper relies on this without support.
At the present time, there are no Food and Drug Administration-approved treatments for FCS.
“At the present time, there are no Food and Drug Administration-approved treatments for FCS.”
The paper relies on this without support.
Short-term ingestion of dietary fat, and even limited alcohol consumption, can result in highly exaggerated TG elevations that place patients at high risk for acute pancreatitis, despite otherwise good adherence with the diet.
“Short-term ingestion of dietary fat, and even limited alcohol consumption, can result in highly exaggerated TG elevations that place patients at high risk for acute pancreatitis, despite otherwise good adherence with the diet.”
The paper relies on this without support.
FCS is diagnosed as severe, refractory HTG in people with a history of acute pancreatitis or recurrent abdominal pain and the absence of other causes (alcoholism, gallstones, uncontrolled diabetes, medications, or medical conditions known to cause HTG).
“FCS is diagnosed as severe, refractory HTG in people with a history of acute pancreatitis or recurrent abdominal pain and the absence of other causes (alcoholism, gallstones, uncontrolled diabetes, medications, or medical conditions known to cause HTG).”
The paper relies on this without support.
The most distinctive clinical feature of FCS is fasting hyperchylomicronemia, which results in lipemic, milky-appearing plasma samples.
“The most distinctive clinical feature of FCS is fasting hyperchylomicronemia, which results in lipemic, milkyappearing plasma samples.”
The paper relies on this without support.
There are no randomized controlled trials or meta-analyses, in part due to rareness of the condition.
“There are also no randomized controlled trials or meta-analyses, in part due to rareness of the condition.”
The paper relies on this without support.
HTG increases the severity of acute pancreatitis.
“HTG increases the severity of acute pancreatitis.”
The paper relies on this without support.
A nutrition facts label may be rounded and not indicate the absolute amount of fat in foods.
“It is important to note that a nutrition facts label may be rounded and not indicate the absolute amount of fat in foods.”
The paper relies on this without support.
An individual's recommended fat intake varies based on age and caloric needs, and may need to be modified during pregnancy and for special populations (eg, diabetes).
“An individual's recommended fat intake varies based on age and caloric needs, and may need to be modified during pregnancy and for special populations (eg, diabetes) as is discussed later in this article.”
The paper relies on this without support.
The body can produce all fatty acids except the EFAs, LA, an omega-6 fatty acid, and ALA, an omega-3 fatty acid.
“The body can produce all fatty acids except the EFAs, LA, an omega-6 fatty acid, and ALA, an omega-3 fatty acid.”
The paper relies on this without support.
As EFAs, LA and ALA must be ingested by individuals of all ages.
“As EFAs, LA, and ALA must be ingested by individuals of all ages.”
The paper relies on this without support.
Data is limited in humans regarding the minimum requirements of LA and ALA.
“Data is limited in humans regarding the minimum requirements of LA and ALA.”
The paper relies on this without support.
Over-the-counter omega-3 or fish oil supplements are not recommended due to lack of regulation by the Food and Drug Administration and lower concentration of eicosapentaenoic acid and docosahexaenoic acid in over-the-counter supplements vs prescription.
“It is important to note that over-the-counter omega-3 or fish oil supplements are not recommended due to lack of regulation by the Food and Drug Administration and lower concentration of eicosapentaenoic acid and docosahexaenoic acid in over-thecounter supplements vs prescription.”
The paper relies on this without support.
MCT oil is a medical food available via prescription and should not be confused with coconut oil, which provides additional long-chain triglyceride (LCT) as well as lauric acid (C12).
“MCT oil is a medical food available via prescription and should not be confused with coconut oil, which provides additional long-chain triglyceride (LCT) as well as lauric acid (C12).”
The paper relies on this without support.
Much of lauric acid is absorbed via the chylomicron-dependent pathway.
“It is important to note that much of lauric acid is absorbed via the chylomicron-dependent pathway.”
The paper relies on this without support.
Coconut oil has both medium-chain and long-chain fatty acids, whereas medical grade MCT oil contains only medium-chain fatty acids (ie, C8 and C10).
“Coconut oil has both medium-chain and long-chain fatty acids, whereas medical grade MCT oil contains only medium-chain fatty acids (ie, C8 and C10).”
The paper relies on this without support.
MCT oils sold over the counter may also contain lauric acid and are not recommended for consumption by patients with FCS.
“MCT oils sold over the counter may also contain lauric acid and are not recommended for consumption by patients with FCS.”
The paper relies on this without support.
Low-fat or fat-free, protein-rich foods allow individuals to meet their specific protein requirements while maintaining overall recommended fat restriction.
“Low-fat or fat-free, protein-rich foods allow individuals to meet their specific protein requirements while maintaining overall recommended fat restriction.”
The paper relies on this without support.
Protein-rich foods high in unsaturated fat, such as salmon, nuts, and seeds, would not be appropriate in the recommended diet as long-chain saturated fat, trans fat, and unsaturated fat are all metabolized using the LPL-dependent pathway.
“It is important to note that protein-rich foods high in unsaturated fat, such as salmon, nuts, and seeds, would not be appropriate in the recommended diet as long-chain saturated fat, transfat, and unsaturated fat are all metabolized using the LPL-dependent pathway.”
The paper relies on this without support.
Alcohol interferes with normal TG metabolism and promotes the accumulation of fat in the liver, which subsequently leads to increase in blood chylomicron levels and HTG.
“Alcohol interferes with normal TG metabolism and promotes the accumulation of fat in the liver, which subsequently leads to increase in blood chylomicron levels and HTG.”
The paper relies on this without support.
Individuals with FCS must maintain adequate fluid intake to assist in maintaining hydration and proper pancreatic function.
“Individuals with FCS must maintain adequate fluid intake to assist in maintaining hydration and proper pancreatic function.”
The paper relies on this without support.
Water intake is necessary for digestion.
“Water intake is necessary for digestion.”
The paper relies on this without support.
Patients with FCS have a higher risk of complications, especially acute pancreatitis during pregnancy.
“Patients with FCS have a higher risk of complications, especially acute pancreatitis during pregnancy.”
The paper relies on this without support.
This patient population is at risk for malabsorption and impaired insulin and glucagon secretion due to loss of exocrine and endocrine function.
“This patient population is at risk for malabsorption and impaired insulin and glucagon secretion due to loss of exocrine and endocrine function.”
The paper relies on this without support.
Patients with pancreatogenic diabetes have impaired metabolism of fats, which may result in deficiencies in fat-soluble vitamins, particularly vitamin D.
“Patients with pancreatogenic diabetes have impaired metabolism of fats, which may result in deficiencies in fat-soluble vitamins, particularly vitamin D.”
The paper relies on this without support.
Glycemic control is an important part of TG reduction, as well as prevention of diabetes-related complications.
“Glycemic control is an important part of TG reduction, as well as prevention of diabetes-related complications.”
The paper relies on this without support.
Recurrent acute pancreatitis from persistently elevated TGs increases the risk of chronic pancreatitis due to irreversible damage to the pancreas.
“Recurrent acute pancreatitis from persistently elevated TGs increases the risk of chronic pancreatitis due to irreversible damage to the pancreas.”
The paper relies on this without support.
Patients exhibiting gastrointestinal symptoms of diarrhea, gas, bloating, and unexplained weight loss may be at risk for exocrine pancreatic insufficiency.
“Patients exhibiting gastrointestinal symptoms of diarrhea, gas, bloating, and unexplained weight loss may be at risk for exocrine pancreatic insufficiency (EPI).”
The paper relies on this without support.
At this time, the percentage of patients with FCS who develop EPI and chronic pancreatitis is unknown.
“At this time, the percentage of patients with FCS who develop EPI and chronic pancreatitis is unknown.”
The paper relies on this without support.
Diet and lifestyle are the mainstays of FCS management to decrease TG levels and reduce the likelihood of pancreatitis.
“Diet and lifestyle are the mainstays of FCS management to decrease TG levels and reduce the likelihood of pancreatitis.”
The paper relies on this without support.
Even with strict diet adherence, some patients still experience acute pancreatitis, elevated TGs, and other complications, and struggle with daily discomfort.
“Even with strict diet adherence, some patients still experience acute pancreatitis, elevated TGs, and other complications, and struggle with daily discomfort.”
The paper relies on this without support.
TGs below 2000 mg/dL may prevent pain in some patients with FCS.
“TGs below 2000 mg/dL may prevent pain in some patients, and maintenance of TGs below 1000 mg/dL is the target for patients with FCS.”
The paper relies on this without support.
The very-low-fat diet is essential for FCS.
“These guidelines are intended to help RDNs, clinicians, patients with FCS, their families, and caregivers manage the very-low-fat dietary pattern essential for FCS.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Severely fat-restricted diets may be useful to reduce chylomicronemia and hypertriglyceridemia but are difficult to maintain in the long term. 16”
From Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome (2024) · cites this paper as [16]
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
Patient Self-management of Chronic Disease in Primary Care
Bodenheimer, T. (2002) · JAMA · doi:10.1001/jama.288.19.2469 · Cited by 3,598
Simplified calculation of body surface area
(1987) · New England Journal of Medicine · doi:10.1056/nejm198710223171717 · Cited by 3,238
American College of Gastroenterology guideline: management of acute pancreatitis
Tenner, S., Baillie, J., DeWitt, J., & Vege, S. S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.218 · Cited by 2,327 · cited 1×
“During attacks of acute pancreatitis, early aggressive IV hydration with 250 to 500 mL/h may prevent intravascular volume depletion and pancreatic necrosis.(50,51) Ideally, initiating IV hydration within the first 12 hours of acute pancreatitis onset may prevent further complications.”
BackgroundPractice guidelines in acute pancreatitis
Banks, P. A., Freeman, M. L., & the Practice Parameters Committee of the American College of Gastroenterology (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00856.x · Cited by 2,050
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Medium-chain triglycerides: an update
Bach, A., & Babayan, V. (1982) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.950 · Cited by 1,151
Motivational interviewing in health care: helping patients change behavior
(2008) · Choice Reviews Online · doi:10.5860/choice.45-6211 · Cited by 907
Flagged first, then by citations
2 of the 62 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- McCray, 2011, Nutritional management of chyle leaks: an update, Pract Gastroenterol, 35, 12
- Tenner, 2013, American College of Gastroenterology Guideline: Management of Acute Pancreatitis, Am J Gastroenterol, 22, 433
Cited by
Sorted by citations
Items 101–124 of 124
Arslan, S., Abuşoğlu, Y., Altınkaynak, K., & Kahveci, H. (2024) · Cureus · doi:10.7759/cureus.57019
Volanesorsen and familial chylomicronemia syndrome
BARROS, C. T., Boente, R., A Martínez González, & Fojón, M. S. (2023) · MOJ Surgery · doi:10.15406/mojs.2023.11.00235
Novel approaches to treat primary hyperlipidemia
Vachhani, J. M., & Tirgar, P. (2024) · American Journal of Biopharmacy and Pharmaceutical Sciences · doi:10.25259/ajbps_7_2024
Quilomicronemia familiar: nuevas perspectivas
Echevarría, A. B., Corbo, M. J. A., Muñiz-Grijalvo, O., & Díaz-Díaz, J. L. (2024) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2024.10.006
Familial chylomicronemia: New perspectives
Echevarría, A. B., Corbo, M. J. A., Muñiz-Grijalvo, O., & Díaz-Díaz, J. L. (2024) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2025.100747
Nutrition in Children with Dyslipidemia
(2025) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610027700-ch29
Gong, Z., Xia, Y., Sun, C., Zheng, W., Du, T., Liang, L., Wang, R., Zhang, K., Yang, Y., Sun, M., et al. (2024) · Journal of clinical lipidology · doi:10.1016/j.jacl.2024.07.010
Personalized Medical Diet Recommendations for Disease Management and Improved Patient Outcomes
Kemothi, S., Singh, S., & Varma, P. (2023) · Seminars in Medical Writing and Education · doi:10.56294/mw2023127
Akash, M. S. H., & Rehman, K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36312-2.00005-x
de Meneses, A. B., Irber, I., & de Matos, F. D. (2025) · Health Residencies Journal - HRJ · doi:10.51723/hrj.v6i30.839
A Nutritional Conundrum: Feeding Options in Neonatal Congenital Lipodystrophy
Rajkumar, R., Varikkottil, M. M., Pournami, F., & Jain, N. (2025) · Journal of Neonatology · doi:10.1177/09732179251362605
Joshy, J., Javed, A., Singh, M. K., Singh, B., Kumar, R., & Hussain, S. (2025) · Cureus · doi:10.7759/cureus.96715 · Cited by 1
Familial chylomicronemia in children: clinical cases
Sadykova, D. I., Рашидовна, С. Д., Шакирова, А. Р., Sayfullina, R. M., Damotsev, I. V., Bulatova, А. K., Gagieva, Z. A., Хабибрахманова, З. Р., & Сластникова, Е. С. (2025) · Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) · doi:10.21508/1027-4065-2025-70-5-91-96
Neonatal severe hypertriglyceridaemia: A novel lipoprotein lipase gene splicing variant
Kumar, P. A., & Hari Prasath, C. (2025) · BMJ Case Reports · doi:10.1136/bcr-2025-268368
Makhmudova, U., Schulze, P. C., Lorkowski, S., März, W., Geiling, J.-A., & Weingärtner, O. (2024) · Figshare · doi:10.6084/m9.figshare.26732413
Spoială, E.-L., Oltean, C., Vasiliu, I., Păduraru, G., Danilă, D.-C., Ghiga, G., Țugui, M., Butnariu, L. I., Cojocaru, E., & Trandafir, L. M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15020636
Vega, J. A., Torres, B., Alberto Maiz, G., & Santos, J. L. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1749264
McKenzie, Y. A., Todd, C. J., Heal, C., & Burden, S. T. (2026) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.70216
Clinical identification of familial chylomicronemia syndrome and novel therapeutic options
Hang, S., & Hegele, R. A. (2026) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2026.2661212
Mesures nutritionnelles dans les hypertriglycéridémies : théorie bien définie, pratique complexe
Monnier, L., Schlienger, J.-L., & Colette, C. (2026) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2026.06.004
Lipemia Retinalis in an Infant With a PCSK9 Variant of Familial Hypercholesterolemia: A Case Report
Ismail, A. Z., Wong, C. L., & Tai, E. L. M. (2026) · Cureus · doi:10.7759/cureus.112310
Österreichischer Lipidkonsensus 2026
Kronenberg, F., Höllerl, F., Brath, H., Rega‐Kaun, G., Greber‐Platzer, S., Weiser, C., Klein, D. P., Riesenhuber, N., Binder, C. J., Brix, J. M., et al. (2026) · Wiener klinische Wochenschrift · doi:10.1007/s00508-026-02760-6
Liu, J., Meng, X., Wu, Y., Huang, G., & Liang, S. (2026) · Clinical Case Reports · doi:10.1002/ccr3.73207
Chan, S. Y. C., Yau, H. C., Chan, K. Y., & Fu, A. (2026) · Cureus · doi:10.7759/cureus.114010
Metadata
- Authors
- Williams, L., Rhodes, K. S., Karmally, W., Welstead, L. A., Alexander, L., & Sutton, L.
- Affiliations
- Cook Children's Medical Center (US)
- Michigan Medicine (US)
- Columbia University (US)
- University of Chicago (US)
- Jacksonville Center for Clinical Research (US)
- Corresponding author
- Williams, Lauren
- Venue
- Journal of Clinical Lipidology
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 12
- Issue
- 4
- Pages
- 908-919
- ISSN
- 1876-4789 (ISSN-L)
- 1933-2874
- OpenAlex
- W2802917102
- Semantic Scholar
- 586a80b6c372497b316fad44f6486f8338a7fdf7
- Cited by
- 125
- References
- 62
- Citations by year
- 2026: 15 · 2025: 23 · 2024: 22 · 2023: 19 · 2022: 12 · 2021: 13 · 2020: 9 · 2019: 8 · 2018: 4
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of clinical lipidology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Ionis Pharmaceuticals
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Keywords
- familial chylomicronemia syndrome, lipoprotein lipase deficiency, very low-fat diet, nutritional therapy, dietary guidelines, hypertriglyceridemia, pancreatitis, essential fatty acids, medium-chain triglyceride oil, fat-soluble vitamins, carbohydrate intake, weight management, patient-centered care
- MeSH terms
- Energy Intake, Humans, Life Style, Hyperlipoproteinemia Type I, Longevity, Pancreatitis, Guidelines as Topic, Diet, Fat-Restricted, Nutrition Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-08, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-08 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
